Medulloblastoma is an invasive embryonal tumor of the cerebellum with predominant neuronal differentiation. Although several hereditary cancer syndromes have been implicated in medulloblastoma formation, such as Turcot, Gorlin, and Li Fraumeni syndrome, the majority of these tumors cannot be explained by mutations in genes and most medulloblastomas appear sporadically. A 6-yearold girl previously diagnosed with Turner syndrome presented with ataxia and symptoms of raised intracranial pressure. Diagnostic workup disclosed a posterior fossa tumor. Histopathologic study of the excised neoplasm showed a medulloblastoma. The current literature was reviewed; no case of medulloblastoma and Turner syndrome that has been verified on pathologic examination has been reported to date.
M edulloblastomas, embryonal neoplasms arising in the cerebellum, are the most common malignant brain tumors in children. [1] [2] [3] These tumors comprise approximately 20% of all pediatric central nervous system (CNS) neoplasms. 1, 3 Significant progress has been made in the treatment of medulloblastoma, but large gaps still exist in our understanding of the origin, genetic features, and pathogenesis of this malignancy. Most medulloblastomas appear sporadically; however, their incidence is elevated in inherited tumor predisposition syndromes. [1] [2] [3] We present here the case of a 6-year-old girl who had Turner syndrome and medulloblastoma.
CASE REPORT
A 6-year-old girl previously diagnosed with Turner syndrome (karyotype was 45, X0; Fig. 1 ) presented with headache, vomiting, and ataxia. On physical examination, she had short stature, a broad chest, a small mandible, prominent ears, cubitus valgus, and a short neck with a low posterior hairline. Neurologic examination revealed bilateral papilledema and ataxia.
Magnetic resonance imaging (MRI) showed isointense and slightly hypointense to gray matter on the T1-weighted images and a homogeneous contrast-enhancing solid lesion located within the right cerebellopontine angle (CPA; Fig. 2 ). The results of the systemic investigations were normal.
A right suboccipital craniotomy was performed, and total tumor resection was achieved. Histologic examination revealed a medulloblastoma. One week after surgery, the patient was discharged for chemotherapy and radiotherapy.
DISCUSSION
Normal neuronal development is dependent on the activation of membrane-bound receptors by polypeptide growth factors and the subsequent transduction of these messages by intracellular pathways. There is increasing evidence in the literature that dysregulation of genes encoding elements within these pathways significantly contributes to the development of CNS malignancies, including medulloblastomas. 4, 5 Medulloblastoma is an invasive embryonal tumor of the cerebellum with predominant neuronal differentiation. Although several genes have been implicated in medulloblastoma formation, such as Patched (Ptc1) and the adenomatous Polyposis coli gene (APC), the majority of these tumors cannot be explained by mutations in these genes. 1, 3, 6 A few cases of medulloblastoma occur in the setting of hereditary cancer syndromes, including Turcot, Gorlin, and Li Fraumeni syndrome. [1] [2] [3] 7 Gorlin syndrome results from inherited defects in the Hedgehog pathway gene patched (PTCH). Mutations in the Hedgehog pathway members have been identified in approximately 25% of sporadic medulloblastomas as well. 2 Turcot syndrome is caused by germline mutations in the APC gene and has been identified in approximately 25% of sporadic medulloblastomas. 2 Li Fraumeni syndrome is caused by inherited mutations in the p53 tumor suppressor gene. 2 Affected individuals develop a large spectrum of CNS and extra-CNS tumors, including medulloblastomas. 8 Interestingly, alterations in p53 are relatively rare in sporadic medulloblastomas, with an incidence of approximately 5%. 2, 9 Turner syndrome is one of the most common monosomies in live-born human beings and is often accompanied by cardiovascular disorders. The chromosomal finding in Turner syndrome is the loss of part or all of one of the sex chromosomes. Half of the affected individuals have 45, X0 in their lymphocyte studies. The other half have a variety of abnormalities of one of their sex chromosomes and may be mosaic. 10 We encountered a case of Turner syndrome with medulloblastoma. To our knowledge, no case of coincidental medulloblastoma and Turner syndrome that was verified on pathologic examination has been reported to date. Brun and Skold 11 reported the autopsy finding that a 16-year-old girl with Turner syndrome had died because of repeated bleeding from medulloblastoma, however. As a cause of a molecular mechanism in the formation of medulloblastoma, deletion of regions on the autosomal chromosomes has been shown; however, no abnormality on the sex chromosomes has been shown.
CONCLUSION
The cellular origin as well as the genetic and molecular changes involved in the genesis and progression of medulloblastomas remains largely unknown. Although several genes have been implicated in medulloblastoma formation, these genetic defects have been detected in a small proportion of sporadic tumors. The association of medulloblastoma and Turner syndrome may be a coincidence. Therefore, further genetic and molecular analyses are required to elucidate the role of genetic defects in the development of medulloblastoma. Understanding the significance of these defects will hopefully lead to the development of successful novel treatment approaches for children with medulloblastoma. 
